Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 4/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.51 |
| ▸ | KCNK3 | O14649 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PARP1 | P09874 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 3/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2931801 | 0.78 | AKT1 (0.54) | HDAC1HDAC6MEN1KMT2ANPC1 | |
| SCHEMBL27438056 | 0.78 | HDAC1 (0.61) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL2222999 | 0.77 | HDAC1 (0.69) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL6880530 | 0.77 | CES2 (0.61) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL1507076 | 0.77 | HDAC6 (0.69) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL29649046 | 0.77 | CES2 (0.61) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL29584617 | 0.77 | HDAC6 (0.69) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL31195509 | 0.77 | HDAC1 (0.59) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL2923972 | 0.76 | MEN1 (0.48) | HDAC1HDAC6CES2CES1MEN1 | |
| SCHEMBL2923969 | 0.75 | HDAC1 (0.57) | HDAC1HDAC6CES2CES1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7732550-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MITI (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-0922715-B1 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY IND SCIENCE TECHN (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-6858694-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 2005-02-22 | — | — | US | disclosed |
| US-6852819-B2 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | AGENCY OF INDUSTRIAL SCIENCE & TECHNOLOGY MITI (JP) | 2005-02-08 | — | — | US | disclosed |
| US-20040223947-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
| US-20040223945-A1 | Stimuti-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2004-11-11 | — | — | US | disclosed |
| US-20020188084-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | JNC CORPORATION (JP) | 2002-12-12 | — | — | US | disclosed |
| EP-0922715-A2 | Stimuli-responsive polymer utilizing keto-enol tautomerization | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY MITI (JP) | 1999-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040223945-A1 | Stimuti-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | CREB1, STIM2, GABRE | HDAC1 3570/4885HDAC6 3951/4885CES2 1208/4885 |
| US-20040223947-A1 | Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same | ACMSD, ADSL, CREB1 | HDAC1 2910/4885HDAC6 2631/4885CES2 1367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.